Subscribe
Subscribe today to receive CGD’s latest newsletters and topic updates.
All Commentary
Filters:
Topics
Facet Toggle
Content Type
Facet Toggle
Blog Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
April 25, 2023
This month, Ghana and Nigeria became the first two countries to approve the use of R21, a vaccine that may have game-changing effectiveness in protecting people from malaria. The emergence of effective vaccines promises a new golden age of success in the fight against malaria, just as such efforts h...
Blog Post
April 20, 2023
Last week in DC was busy with the World Bank and IMF spring meetings, the Consortium of Universities in Global Health (CUGH) 2023 Annual Conference, and other events including the first UN-hosted Asia-Pacific Civil Registration & Vital Statistics (CRVS) Research Forum. Amidst a flurry of events on g...
Blog Post
April 11, 2023
In this blog, we make the case that WHO should shift away from disease siloes and reorganize to streamline the cross-cutting functions that it delivers to member countries. The WHO has an opportunity to streamline its functions along the continuum of science practice—from registering clinical trials...
Blog Post
March 07, 2023
The EU and its member states are collectively the world’s largest aid donor, with an annual budget of over $70 billion in 2021. When it comes to global health, however, it has historically punched below its weight. In part, this is due to an internal coordination problem; health is a shared competen...
Blog Post
February 27, 2023
Global health financing is due for a reckoning. Deteriorating macroeconomic conditions, alongside consequences of the war in Ukraine, and economic scars left by the COVID-19 pandemic have left many low- and middle-income countries (LMICs) with low or negative growth, increasing debt and highly uncer...
Blog Post
December 13, 2022
Earlier this year, the IMF board approved the establishment of the Resilience and Sustainability Trust (RST) to provide financial support to countries addressing long-term structural challenges, including climate change and pandemic preparedness. 143 countries are eligible to receive support from th...
Blog Post
September 26, 2022
Antimicrobial resistance is a major global problem. Today, drug resistant infections kill an estimated 1.27 million people per year, and low- and middle-income countries bear the brunt of AMR-related deaths and illness. Changing how we buy antimicrobials can help solve the problem.